miR-21-mediated tumor growth

Oncogene

Volumn 26, Issue 19, 2007, Pages 2799-2803

  Si, M L ^a   Zhu, S ^a   Wu, H ^a   Lu, Z ^a   Wu, F ^a   Mo, Y Y ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bcl 2; MCF 7; miR 21; miRNA; Post transcriptional regulation

Indexed keywords

MICRORNA; MIR 21 PROTEIN; OLIGONUCLEOTIDE; PROTEIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST; BREAST TUMOR; CANCER INHIBITION; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; XENOGRAFT;

ANIMALS; APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, NUDE; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34247495591     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210083     Document Type: Article

References (25)

1. Bartel DP. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24.
3. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002). Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529.
4. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004.
5. Chan JA, Krichevsky AM, Kosik KS. (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
6. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT et al. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33: e179.
7. Chen CZ, Li L, Lodish HF, Bartel DP. (2004). MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86.
8. Cheng AM, Byrom MW, Shelton J, Ford LP. (2005). Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297.
9. Croce CM, Calin GA. (2005). miRNAs, cancer, and stem cell division. Cell 122: 6-7.
10. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF et al. (2005). Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102: 3627-3632.
11. Fitzgerald K. (2005). RNAi versus small molecules: different mechanisms and specificities can lead to different outcomes. Curr Opin Drug Discov Dev 8: 557-566.
12. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
13. Kim VN. (2005). MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385.
14. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
15. Lao K, Xu NL, Yeung V, Chen C, Livak KJ, Straus NA. (2006). Multiplexing RT-PCR for the detection of multiple miRNA species in small samples. Biochem Biophys Res Commun 343: 85-89.
16. Lee RC, Feinbaum RL, Ambros V. (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
17. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. (2004). High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39: 167-169.
18. Michael MZ, SM OC, van Holst Pellekaan NG, Young GP, James RJ. (2003). Reduced accumulation of specific micro-RNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891.
19. Mo YY, Yu Y, Ee PL, Beck WT. (2004). Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs. Cancer Res 64: 2793-2798.
20. Pillai RS. (2005). MicroRNA function: multiple mechanisms for a tiny RNA? RNA 11: 1753-1761.
21. Tang F, Hajkova P, Barton SC, Lao K, Surani MA. (2006). MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 34: e9.
22. Tanizawa A, Fujimori A, Fujimori Y, Pommier Y. (1994). Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials. J Natl Cancer Inst 86: 836-842.
23. Wightman B, Ha I, Ruvkun G. (1993). Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855-862.
24. Zamore PD, Haley B. (2005). Ribo-gnome: the big world of small RNAs. Science 309: 1519-1524.
25. Zhang W, Ran S, Sambade M, Huang X, Thorpe PE. (2002). A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model. Angiogenesis 5: 35-44.